Table 2.

Results, secondary outcomes

Outcome	Baseline	Active			Baseline	Sham
		End	1 month	p value		End	1 month	p value
JTTper (%)	40.7 ± 35.7	46.1 ± 37.3	52.9 ± 31.9	0.03	44.4 ± 39.4	46.3 ± 38.6	50.3 ± 40.4	0.46
PF (N)	0.27 ± 0.23	0.31 ± 0.23	0.32 ± 0.32	0.008	0.29 ± 0.28	0.33 ± 0.31	0.34 ± 0.27	0.441
AS	0 (0–2)	0 (0–2)	1 (0–3)	0.549	0 (0–3)	0.5 (0–2)	0.5 (0–3)	0.846
FM (UL)	108 (61–123)	114 (59–123)	111 (62–120)	0.038	97.5 (50–119)	105.5 (58–121)	107.5 (49–125)	0.001
MRS	3 (2–4)	3 (1–4)	2 (1–4)	0.016	3 (0–4)	3 (0–4)	3 (0–5)	0.037

Means ± standard deviations, or medians (ranges) are shown. Friedman’s tests were performed

End At end of treatment, 1 month 1 month after end of treatment JTT_per Jebsen–Taylor test (% affected hand/unaffected hand), PF pinch force of the paretic hand, N Newtons, FM (UL) Fugl-Meyer (upper limb, total score; maximum = 126), AS Ashworth Scale, MRS Modified Rankin Scale

p-values ≤ 0.05 are highlighted in bold